• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Hepatic Resection Compared to Chemoembolization in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Comment For Moving Forward.

作者信息

Mo Dun-Chang, Jia Rong-Rong, Zhong Jian-Hong

机构信息

Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

出版信息

Hepatology. 2019 Jul;70(1):446-447. doi: 10.1002/hep.30409.

DOI:10.1002/hep.30409
PMID:30520102
Abstract
摘要

相似文献

1
Letter to the Editor: Hepatic Resection Compared to Chemoembolization in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Comment For Moving Forward.致编辑的信：中晚期肝细胞癌肝切除与化疗栓塞术的比较：迈向未来的评论
Hepatology. 2019 Jul;70(1):446-447. doi: 10.1002/hep.30409.
2
Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma.肝切除术在治疗中期肝细胞癌方面优于经动脉化疗栓塞术。
Liver Int. 2017 Jul;37(7):1083-1084. doi: 10.1111/liv.13290. Epub 2016 Nov 19.
3
Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question.中期肝细胞癌（BCLC-B期）的手术切除与经动脉化疗栓塞术：一个未解决的问题。
Hepatology. 2019 Feb;69(2):923. doi: 10.1002/hep.30338.
4
Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.肝切除术联合化疗栓塞治疗肝细胞癌。
Hepatogastroenterology. 2003 May-Jun;50(51):750-5.
5
ASO Author Reflections: The Role of Postoperative Adjuvant Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Hepatic Vein Invasion.ASO作者反思：经动脉化疗栓塞术在肝细胞癌合并肝静脉侵犯患者术后辅助治疗中的作用
Ann Surg Oncol. 2019 Dec;26(Suppl 3):709-710. doi: 10.1245/s10434-019-07672-6. Epub 2019 Aug 29.
6
Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.可切除肝细胞癌的术前经动脉化疗栓塞术对术后患者预后有不利影响。
Aliment Pharmacol Ther. 2008 Feb 15;27(4):338-45. doi: 10.1111/j.1365-2036.2007.03580.x. Epub 2007 Nov 28.
7
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.肝细胞癌伴门静脉侵犯患者手术切除与经动脉化疗栓塞联合额外放射治疗的比较
Clin Mol Hepatol. 2018 Jun;24(2):135-136. doi: 10.3350/cmh.2018.1001. Epub 2018 Feb 22.
8
Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial.肝切除术与经动脉化疗栓塞术治疗肝细胞癌的比较：前瞻性随机试验的必要性
Hepatology. 1992 Sep;16(3):702-6. doi: 10.1002/hep.1840160314.
9
[Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma].[肝切除术与射频消融术或经动脉化疗栓塞术治疗肝细胞癌的疗效比较]
Chirurg. 2018 Jan;89(1):64. doi: 10.1007/s00104-017-0567-0.
10
Liver Resection for Patients with Intermediate Stage Hepatocellular Carcinoma: Beyond Rigid Staging Systems Towards a More Personalized Therapeutic Approach.中期肝细胞癌患者的肝切除术：超越严格的分期系统，迈向更个性化的治疗方法。
J Gastrointest Surg. 2021 Apr;25(4):1078-1079. doi: 10.1007/s11605-021-04963-w. Epub 2021 Mar 3.

引用本文的文献

1
Injectable Hydrogel-Encapsulating Pickering Emulsion for Overcoming Lenvatinib-Resistant Hepatocellular Carcinoma via Cuproptosis Induction and Stemness Inhibition.用于通过诱导铜死亡和抑制干性来克服仑伐替尼耐药性肝细胞癌的可注射水凝胶包裹皮克林乳液
Polymers (Basel). 2024 Aug 26;16(17):2418. doi: 10.3390/polym16172418.
2
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.miR-552调控肝肿瘤起始细胞的扩增及索拉非尼耐药性。
Mol Ther Nucleic Acids. 2020 Mar 6;19:1073-1085. doi: 10.1016/j.omtn.2019.12.043. Epub 2020 Jan 15.